This 1-day virtual course will provide an intensive, topics-based review of basic science topics pertinent to the clinical practice of veterinary oncology.
The diverse and daily expanding field of specialized oncology diagnostics available for dogs and cats makes remaining current on the latest advances challenging. Keeping up-to-date on the latest data is important for presenting case management options to clients along with realistic expectations. In this day-long virtual course, panelists will discuss the available data (or, sometimes, lack thereof) for the somewhat more controversial aspects of veterinary oncology diagnostics, including: Personalized medicine, chemosensitivity assays, liquid biopsy possibilities, and diagnostic/prognostic panels. The potential opportunities and challenges of clinical integration of these diagnostics will be discussed with significant opportunity for open Q&A.
By the end of the course, you will be able to:
1. Recognize the opportunities and limitations for personalized/genomic diagnostics in veterinary oncology
2. Understand the potential clinical utility of chemosensitivity assays in case management and treatment selection
3. Recognize the available diagnostic platforms available for liquid biopsy purposes, along with the potential benefits and challenges of each
4. Describe the available diagnostic and prognostic panels available in veterinary oncology and understand best clinical use of each
5. Incorporate information discussed in this session to your clinical practice and client discussions
RACE Application Status:
On-demand course registration: This program has been approved for 6.5 hours of Anytime, Non-Interactive-distance continuing education credit in jurisdictions which recognize AAVSB RACE-approval.
Participants should be aware that some state boards have limitations on the number of hours accepted in certain categories and/or restrictions on certain methods of delivery of continuing education. Please contact your state board directly with any questions.